Emily Ann Glossop, APRN

Emily Glossop practices at Institute of Endocrinology Diabetes Health and Hormones in Destin, Florida.

Emily Glossop's NPI, 1588295422, was assigned on January 29, 2020. Emily Glossop holds Florida license APRN11005951.

Emily Glossop's primary practice is Institute of Endocrinology Diabetes Health and Hormones, at 1241 Airport Rd, Destin, FL 32541 in Okaloosa County. The practice phone is (850) 522-5490.

Emily Glossop's primary practice is Institute of Endocrinology Diabetes Health and Hormones in Destin, Florida. Emily Glossop is also affiliated with Gulf Breeze Hospital. The medical group on file is Institute of Endocrinology Diabetes, Health & Hormones. Dmand AI also links Emily Glossop to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Emily Glossop practices, 5 sites in all. Vendor and product names are available with a free account.

Family is Emily Glossop's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Emily Glossop is licensed in Florida.

Dmand AI lists chronic diabetes, depression, diabetic emergency, enlarged thyroid, high cholesterol, insomnia, muscle pain, fibromyalgia, and limb pain and osteoporosis among the conditions Emily Glossop treats.

CMS data shows 575 Medicare services from Emily Glossop across 4 procedure codes in 2024, for 191 Medicare patients. Medicare paid $36,986 for them. Every service was in an office.

CMS counts 191 Medicare patients who saw Emily Glossop in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Emily Glossop's median patient age at 54, with 64% women.

In 2024, Emily Glossop wrote 907 Medicare Part D claims for 129 patients. 29% of them were for generic drugs. CMS names the drug for 645 of them, across 18 drugs with 11 or more claims each, at $482,614 in total drug cost.

Emily Glossop accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Emily Glossop as offering telehealth.

CMS Open Payments shows 176 general payments to Emily Glossop from 30 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 79% of the total. Medtronic, Inc. paid the most, $1,732.